Becton Dickinson (BDX) Earnings Expected to Grow: Should You Buy?

Becton Dickinson (BDX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks Investment Research • 9 hours ago

Best Dividend Aristocrats For November 2026

Dividend Aristocrats underperformed SPY in September but rebounded sharply in October, narrowing the YTD gap. NOBL and the average Aristocrat have YTD returns of 13.13% and 13.35%, trailing SPY's 14.15%. Dividend growth among Aristocrats accelerated, with the 2026 average increase now at 4.55%, bolstered by recent double-digit hikes.

Seeking Alpha • 17 hours ago

American Century Equity Income Fund Q3 2026 Portfolio Activity

Becton Dickinson and Co. reported strong quarterly results, improved cash flow and a higher earnings outlook. Kimberly-Clark's shares declined after management lowered its growth outlook amid softer demand trends and disruptions in China. The portfolio's underweight position in Apple relative to the benchmark detracted as optimism around its ecosystem and artificial intelligence opportunities supported the stock during the period.

Seeking Alpha • 16 hours ago

BD Advances Portal Hypertension Care in the U.S. with Support for More Personalized Treatment Options

The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J.

PRNewsWire • Oct 28, 2026

First Eagle Global Fund Q3 202 Portfolio Update

Global Fund A Shares (without sales charge) posted a return of 2.10% in third quarter 2026. Leading contributors in the First Eagle Global Fund this quarter included Workday, Inc. Class A, Meta Platforms, Inc. Class A, Salesforce.com, Inc., Becton, Dickinson and Company and gold bullion. The leading detractors in the quarter were LVMH Moet Hennessy Louis Vuitton SE, Samsung Life Insurance Co., Ltd., Weyerhaeuser Company, British American Tobacco p.l.c. and IPG Photonics Corporation.

Seeking Alpha • Oct 28, 2026

Best Dividend Kings: October 2026

Dividend Kings have outperformed SPY YTD, rising 13.5% versus SPY's 12.32%, with a strong October rebound. Twenty-six Dividend Kings appear both potentially undervalued and offer long-term annualized expected returns of at least 10%. Dividend growth for the Kings in 2026 averages 4.65%, with recent increases from GRC, NWN, and RPM.

Seeking Alpha • Oct 26, 2026

First Eagle U.S. Value Fund Q3 2026 Portfolio Review

U.S. Fund A Shares (without sales charge) posted a return of 4.36% in third-quarter 2026. The US Fund outperformed the S&P 500 Index in the period. Shares of Meta performed well following the strong reception of Muse, its personalized AI assistance app.

Seeking Alpha • Oct 26, 2026

The Dividend Aristocrats Ranked By Quality Scores (October 2026)

I rank all 69 S&P 500 Dividend Aristocrats by my 9F Quality Scores, segmenting them into undervalued, fairly valued, and overvalued groups. My consensus fair value estimates, blending up to 40 data points per stock, highlight 12 undervalued and 18 fairly valued Aristocrats, with 39 currently overvalued. Investment candidates vary by style: ADP, BRO, and NDSN for growth; NEE for total return; PEP and O for income; CAT and GWW for past performance.

Seeking Alpha • Oct 23, 2026

BDX Stock Gains 25.5% in Six Months: What's Behind the Rally?

BD's 25.5% rally reflects stronger execution, portfolio reshaping, product innovation and U.S. manufacturing investments despite tariffs and cost pressures.

Zacks Investment Research • Oct 22, 2026

BD's Revello Stent Shows Strong AGILITY Trial Results for PAD Patients

BDX's Revello stent shows strong nine-month AGILITY trial results, with high vessel patency and low failure rates, boosting its peripheral vascular prospects.

Zacks Investment Research • Oct 15, 2026